Reference
Bernardi S, et al. Azacitidine (AZA) for relapsed high risk myelodysplasic syndrome after intrabone cord blood transplantation: a case report. Haematologica 97 (Suppl. 2): S113-S114 abstr. PO-136, Oct 2012. Available from: URL: http://www.haematologica.org/content/97/supplement_2 [abstract] - Italy
Rights and permissions
About this article
Cite this article
Azacitidine. Reactions Weekly 1531, 30 (2014). https://doi.org/10.1007/s40278-014-5663-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-5663-z